- Home
- CFSB vs CVM Comparison
CFSB vs CVM Comparison
Compare CFSB & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- CVM
- Stock Information
- Founded
- CFSB 1889
- CVM 1983
- Country
- CFSB United States
- CVM United States
- Employees
- CFSB N/A
- CVM N/A
- Industry
- CFSB Major Banks
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFSB Finance
- CVM Health Care
- Exchange
- CFSB Nasdaq
- CVM Nasdaq
- Market Cap
- CFSB 44.7M
- CVM 40.1M
- IPO Year
- CFSB N/A
- CVM 1987
- Fundamental
- Price
- CFSB $6.75
- CVM $0.72
- Analyst Decision
- CFSB
- CVM
- Analyst Count
- CFSB 0
- CVM 0
- Target Price
- CFSB N/A
- CVM N/A
- AVG Volume (30 Days)
- CFSB 8.9K
- CVM 983.5K
- Earning Date
- CFSB 01-24-2025
- CVM 02-12-2025
- Dividend Yield
- CFSB N/A
- CVM N/A
- EPS Growth
- CFSB N/A
- CVM N/A
- EPS
- CFSB N/A
- CVM N/A
- Revenue
- CFSB $7,444,000.00
- CVM N/A
- Revenue This Year
- CFSB N/A
- CVM N/A
- Revenue Next Year
- CFSB N/A
- CVM $3,412.81
- P/E Ratio
- CFSB N/A
- CVM N/A
- Revenue Growth
- CFSB N/A
- CVM N/A
- 52 Week Low
- CFSB $6.21
- CVM $0.49
- 52 Week High
- CFSB $7.95
- CVM $3.23
- Technical
- Relative Strength Index (RSI)
- CFSB 52.19
- CVM 52.33
- Support Level
- CFSB $6.60
- CVM $0.60
- Resistance Level
- CFSB $6.82
- CVM $1.09
- Average True Range (ATR)
- CFSB 0.12
- CVM 0.12
- MACD
- CFSB 0.01
- CVM 0.02
- Stochastic Oscillator
- CFSB 79.07
- CVM 38.40
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.